financetom
Business
financetom
/
Business
/
Saylor's Strategy reports fifth consecutive quarterly loss, announces $21 billion equity offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Saylor's Strategy reports fifth consecutive quarterly loss, announces $21 billion equity offering
May 25, 2025 11:55 PM

(Reuters) -Strategy, the biggest corporate holder of bitcoin, reported a fifth consecutive quarterly loss on Thursday due to an unrealized loss on its cryptocurrency holdings.

Bitcoin surged to record highs following Donald Trump's November 2024 presidential election victory, propelling the shares of Strategy to an all-time high, which contributed to earning it a spot in the Nasdaq 100 index in December.

However, a wave of sweeping tariffs announced by Trump has since unsettled global markets, dampening risk appetite and potentially triggering investors to pull away from the crypto markets. 

Michael Saylor's Strategy, formerly MicroStrategy ( MSTR ), reported a quarterly loss of $5.91 billion from its digital assets due to a quarter-end bitcoin price of $82,445.

Strategy moved to a new accounting rule in the first quarter, which allows the company to fairly value its unrealized gains or losses on its crypto holdings.

"One fundamental difference now under fair value accounting is that our holdings are marked on the last day of every quarter, not throughout the quarter as before," said financial chief Andrew Kang on a post-earnings call.

The company also announced a new $21 billion at-the-market common stock equity offering and intends to use proceeds for further acquisition of bitcoin.

The Tysons Corner, Virginia-based company held 553,555 bitcoins for $37.90 billion as of April 28, 2025.

Strategy's net loss was $4.22 billion, or $16.49 per share, in the three months ended March 31, compared to a loss of $53.1 million, or $0.31 per share, a year earlier.

In March 2025, GameStop announced its board's unanimous decision to add bitcoin as a treasury reserve asset, aligning with the Strategy's approach. 

This move highlights how companies are exploring alternative assets such as bitcoin to bolster their financial positions, especially when traditional revenue streams face headwinds.

Strategy shares are up about 32% so far this year, compared with a near 6% fall in the Nasdaq 100 index.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
FleetPride and TruckPro Announce Strategic Merger
FleetPride and TruckPro Announce Strategic Merger
Oct 28, 2025
IRVING, Texas and MEMPHIS, Tenn., Oct. 28, 2025 /PRNewswire/ -- FleetPride Inc. (FleetPride) and TruckPro, LLC (TruckPro) jointly announced the closing of a merger of the two companies effective today, creating the nation's leading independent distributor and service provider in the heavy-duty aftermarket parts industry. The combined company will operate under the FleetPride name and will deliver enhanced value to...
Vicor Insider Sold Shares Worth $498,863, According to a Recent SEC Filing
Vicor Insider Sold Shares Worth $498,863, According to a Recent SEC Filing
Oct 28, 2025
11:55 AM EDT, 10/28/2025 (MT Newswires) -- Claudio Tuozzolo, Director, Corporate Vice President, on October 24, 2025, sold 5,508 shares in Vicor ( VICR ) for $498,863. Following the Form 4 filing with the SEC, Tuozzolo has control over a total of 33,622 common shares of the company, with 33,622 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/751978/000140354025000007/xslF345X05/primary_doc.xml Price: 89.93, Change: -0.07,...
Pharmaron Acquires Biortus in China
Pharmaron Acquires Biortus in China
Oct 28, 2025
To Further Enhance Structure-Based Drug Discovery and Protein Science Service Capabilities​​ BEIJING--(BUSINESS WIRE)-- Pharmaron Beijing Co., Limited ( PHBBF ) (Stock Code: 300759.SZ/3759.HK) (hereinafter referred to as “Pharmaron” and the “Company”) today announced that it has entered into a definitive Share Purchase Agreement to acquire 82.54% equity interest of Biortus Biosciences Co., Ltd. and its affiliates (hereinafter referred to as...
Lam Research Insider Sold Shares Worth $1,418,775, According to a Recent SEC Filing
Lam Research Insider Sold Shares Worth $1,418,775, According to a Recent SEC Filing
Oct 28, 2025
11:55 AM EDT, 10/28/2025 (MT Newswires) -- Ava Harter, Chief Legal Officer, on October 27, 2025, sold 9,010 shares in Lam Research ( LRCX ) for $1,418,775. Following the Form 4 filing with the SEC, Harter has control over a total of 56,786 common shares of the company, with 56,786 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/707549/000164241525000005/xslF345X05/wk-form4_1761666777.xml Price: 155.61, Change: -1.30,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved